<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="[!info]
ğŸŒ± ä¾†è‡ª: [[5-Fluorouracil]]
 Capecitabine  &ldquo;Xeloda Tablet&rdquo; 500 mg/tab
  Dosing:  1,000-1,250 mg/m2 PO twice daily Ã— 2 wks every 21 d."><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-mlkgi530p-htlin222.vercel.app/api/blog?templateTitle=Capecitabine"><title>Capecitabine</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.720e2c4835986a3891d6eef3a55faa22.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.9422ebf6ba0889a950feb47330bafa38.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.8c890c0ab5916d5b1ce74859205052b4.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'â€™':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=æœå°‹ placeholder="è«‹è¼¸å…¥åƒæ˜¯ï¼šhypertension ä¹‹é¡çš„ä¾†çœ‹æ²’æœ‰æ²’ä»€éº¼æœ‰è¶£çš„ğŸ³"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>èœ¥èœ´èŠ±åœ’ğŸ¦ğŸŒ±ğŸª´ğŸŒ²</a></h1><div class=spacer></div><div id=search-icon><p>æœå°‹</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">æœå°‹åœ–ç¤º</title><desc id="desc">æ‰“é–‹æœå°‹åœ–æ¨™</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>æ˜äº®æ¨¡å¼</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>é»‘æš—æ¨¡å¼</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Capecitabine</h1><p class=meta>æœ€å¾Œæ›´æ–°æ–¼
Sep 5, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Capecitabine.md rel=noopener>ğŸªš ç·¨è¼¯åŸå§‹æ–‡ä»¶</a></p><ul class=tags><li><a href=https://www.physician.tw/tags/building/>building</a></li></ul><blockquote class=info-callout><p></p><p>ğŸŒ± ä¾†è‡ª: <a href=/fluorouracil rel=noopener class=internal-link data-src=/fluorouracil>5-Fluorouracil</a></p></blockquote><a href=#capecitabine><h1 id=capecitabine><span class=hanchor arialabel=Anchor># </span>Capecitabine</h1></a><blockquote><p>&ldquo;Xeloda Tablet&rdquo; 500 mg/tab</p></blockquote><ul><li>Dosing:<ul><li>1,000-1,250 mg/m2 PO twice daily Ã— 2 wks every 21 d.</li><li>Renal: CrCl 30-50 mL/min: 75% of dose; CrCl &lt;30 mL/min: use contraindicated</li></ul></li><li>PK/PD:<ul><li>Oral prodrug of 5-FU, converted via <a href=/step-activation-process-of-capecitabine rel=noopener class=internal-link data-src=/step-activation-process-of-capecitabine>3-step activation process</a> ó°’–.</li><li>Bioavailability âˆ¼80%, protein binding &lt;60%, hepatic & tissue metabolism (active metabolite: 5-FU), renal excretion (96%), T1/2 0.5-1 h</li></ul></li><li>AEs:<ul><li>Diarrhea,</li><li><a href=/hand-foot-syndrome rel=noopener class=internal-link data-src=/hand-foot-syndrome>hand-foot syndrome</a>,</li><li>myelosuppression,</li><li>mucositis,</li><li>neurologic tox,</li><li>coronary vasospasm</li></ul></li><li>DDI: Inhibits CYP2C9 weakly, warfarin (BBW), oral anticoagulants (â†‘ levels of anticoagulants), phenytoin (â†‘ levels of phenytoin), leucovorin (â†‘ tox of capecitabine)</li><li>Clinical pearls: Increased risk of fatal/sev. AEs w/ DPD deficiency. Available as 150-mg & 500-mg tablets, take w/in 30 min after a meal, radiation sensitizer, uridine triacetate used as antidote in cases of overdose, accidental ingestion, & possible DPD deficiency</li></ul><p><a href=/three-step-metabolic-conversion-of-capecitabine-to-fluorouracil rel=noopener class=internal-link data-src=/three-step-metabolic-conversion-of-capecitabine-to-fluorouracil>Three-step metabolic conversion of capecitabine to fluorouracil</a></p><hr><ul><li>Used alone as adjuvant therapy following the complete resection of primary tumor in patients with stage III (Dukesâ€™ C) colon cancer when treatment with fluoropyrimidine therapy alone is â†’ preferred. [ref]</li><li>Combined therapy with IV oxaliplatin</li><li>is â†’ a reasonable choice (accepted, treatment option) as adjuvant therapy following complete resection of primary tumor in patients with stage III colon cancer. [ref]</li><li>Initial (first-line) treatment of metastatic colorectal cancer when fluoropyrimidine therapy alone is â†’ preferred.</li><li>Potential inhibition of CYP2C9.</li></ul><a href=#contraindications><h2 id=contraindications><span class=hanchor arialabel=Anchor># </span>Contraindications</h2></a><ul><li>Severe renal impairment (Clcr &lt;30 mL/minute). [ref]</li><li>Warnings/Precautions<ul><li>Coagulopathy</li><li>Generally occurs within several days to months following initiation of therapy; similar events reported in at â†£ least a few patients within 1 month following discontinuance of therapy.</li><li>Alterations in anticoagulant effect associated with capecitabine therapy reported in patients with or without liver metastases. [ref]</li><li>Age >60 years and diagnosis of cancer are independent variables predisposing patients to an increased risk of coagulopathy. [ref]</li><li>Monitor anticoagulant response (PT or INR) frequently, and adjust the anticoagulant dose accordingly in patients receiving concomitant therapy. [ref](See Specific Drugs under Interactions.)
<a href=/fluoropyrimidines rel=noopener class=internal-link data-src=/fluoropyrimidines>fluoropyrimidine</a></li></ul></li></ul><a href=#ç¬¬ä¸‰ä»£-fluoropyrimidine-è—¥ç‰©-capecitabine-åœ¨çµè…¸ç›´è…¸ç™Œæ²»ç™‚ä¸­çš„--æ‡‰ç”¨-><h2 id=ç¬¬ä¸‰ä»£-fluoropyrimidine-è—¥ç‰©-capecitabine-åœ¨çµè…¸ç›´è…¸ç™Œæ²»ç™‚ä¸­çš„--æ‡‰ç”¨-><span class=hanchor arialabel=Anchor># </span>ç¬¬ä¸‰ä»£ fluoropyrimidine è—¥ç‰© Capecitabine åœ¨çµè…¸ç›´è…¸ç™Œæ²»ç™‚ä¸­çš„ â†’ æ‡‰ç”¨ ğŸ©º</h2></a><ul><li>Capecitabine æ˜¯å±¬æ–¼ç¬¬ä¸‰ä»£çš„ fluoropyrimidine è—¥ç‰©ï¼Œåœ¨2001å¹´è¢«ç¾åœ‹ FDA æ ¸å‡†ç”¨æ–¼çµè…¸ç›´è…¸ç™Œçš„ â†’ æ²»ç™‚ã€‚</li><li>Capecitabine æœƒåœ¨è‚è‡Ÿä¸­ç¶“ç”± carboxylesterase æ°´è§£ï¼Œå†ç¶“ç”± cytidine deaminase è½‰æ›æˆ 5&rsquo;-deoxy-5-fluorouridineï¼Œæœ€å¾Œåœ¨è…«ç˜¤ç´°èƒå…§ç”± thymidine phosphorylase å½¢æˆ5-FUã€‚</li><li>é€™ç¨®é¸æ“‡æ€§çš„ â†’ ä»£è¬éç¨‹èƒ½è®“è…«ç˜¤ç´°èƒå…§èšé›†é«˜æ¿ƒåº¦çš„ â†’ 5-FUï¼Œæé«˜æŠ—ç™Œæ•ˆæœï¼ŒåŒæ™‚æ¸›å°‘ â†“ å…¶ä»–æ­£å¸¸ç´°èƒçš„ â†’ å±éšªæš´éœ²ï¼Œ âˆ´ å› æ­¤å‰¯ä½œç”¨ç›¸å°è¼ƒå°ã€‚</li><li>Capecitabine çš„ â†’ åæ‡‰ç‡ç´„ç‚º24-35%ï¼Œæ•´é«”å­˜æ´»æ™‚é–“ç´„ç‚º11-20å€‹æœˆ<ul><li>ä½µç”¨ LV æ•ˆæœä¸¦ âœ– ä¸æœƒæ›´å¥½ï¼Œ âˆ´ å› æ­¤æ¨™æº–ç™‚ç¨‹ä¸­ âœ– ä¸å»ºè­°åŠ å…¥ LVã€‚ ğŸ©º</li></ul></li></ul><a href=#capecitabine-çš„--ä½œç”¨æ©Ÿåˆ¶-><h2 id=capecitabine-çš„--ä½œç”¨æ©Ÿåˆ¶-><span class=hanchor arialabel=Anchor># </span>Capecitabine çš„ â†’ ä½œç”¨æ©Ÿåˆ¶ ğŸ§¬</h2></a><ul><li>Capecitabine æ˜¯ä¸€ç¨® 5-FU å‰è—¥ï¼Œèƒ½å¤ è¿…é€Ÿåœ°è¢«å®Œæ•´åœ°å¸æ”¶ï¼Œä¸¦ç¶“éä¸‰æ­¥ä»£è¬ä½œç”¨è®Šæˆ 5-FUã€‚<ul><li>å®ƒåœ¨è‚è‡Ÿä¸­è¢«é…¯æ°´è§£é…¶è½‰æ›ç‚º 5&rsquo;-deoxy-5-fluorocytidineï¼Œ</li><li>ç„¶å¾Œåœ¨è…«ç˜¤å’Œè‚ç´°èƒä¸­è¢«èƒå˜§å•¶è„«æ°¨é…¶è½‰æ›ç‚º 5&rsquo;-deoxy-5-fluorouridineï¼Œ</li><li>æœ€å¾Œç”±èƒ¸è…ºå˜§å•¶ç£·é…¸åŒ–é…¶è½‰æ›ç‚º 5-FUã€‚</li></ul></li><li>ç›¸æ¯”æ­£å¸¸çµ„ç¹”ï¼Œè…«ç˜¤ç´°èƒä¸­çš„ â†’ <a href=/thymidine-phosphorylase rel=noopener class=internal-link data-src=/thymidine-phosphorylase>Thymidine phosphorylase</a> èƒ¸è…ºå˜§å•¶ç£·é…¸åŒ–é…¶å«é‡æ›´é«˜ï¼Œ<ul><li>âˆ´ å› æ­¤ Capecitabine èƒ½å¤ åœ¨è…«ç˜¤ç´°èƒä¸­ç”¢ç”Ÿ â†ª æ›´é«˜çš„ 5-FU æ¿ƒåº¦ï¼Œæé«˜æ²»ç™‚æ•ˆæœï¼ŒåŒæ™‚é™ä½ â†“ å°æ­£å¸¸çµ„ç¹”çš„ â†’ æ¯’å‰¯ä½œç”¨ã€‚</li></ul></li></ul><a href=#capecitabine-åœ¨è½‰ç§»æ€§çµç›´è…¸ç™Œæ²»ç™‚ä¸­çš„--ç™‚æ•ˆè©•ä¼°-><h2 id=capecitabine-åœ¨è½‰ç§»æ€§çµç›´è…¸ç™Œæ²»ç™‚ä¸­çš„--ç™‚æ•ˆè©•ä¼°-><span class=hanchor arialabel=Anchor># </span>Capecitabine åœ¨è½‰ç§»æ€§çµç›´è…¸ç™Œæ²»ç™‚ä¸­çš„ â†’ ç™‚æ•ˆè©•ä¼° ğŸ©º</h2></a><ul><li><a href=https://www.nature.com/articles/6601676 rel=noopener>Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials | British Journal of Cancer</a></li><li>æœ¬ç ”ç©¶åˆ©ç”¨ä¾†è‡ªå…©å€‹ç›¸åŒè¨­è¨ˆçš„ III æœŸç ”ç©¶ä¸­å¤§é‡ã€å…·æœ‰è‰¯å¥½ç‰¹å¾µçš„ â†’ è½‰ç§»æ€§çµç›´è…¸ç™Œ (mCRC) æ‚£è€…æ•¸æ“šï¼Œè©•ä¼°äº†å£æœ Capecitabine çš„ â†’ ç™‚æ•ˆã€‚</li><li>ç¸½è¨ˆæœ‰1207åæœªæ¥å—éæ²»ç™‚çš„ mCRC æ‚£è€…è¢«éš¨æ©Ÿåˆ†é…åˆ°å£æœ Capecitabine (æ¯21å¤©å…©æ¬¡1250â€‰mgâ€‰m-2ï¼Œç¬¬1-14å¤©ï¼›n=603) æˆ–éœè„ˆ bolus 5-æ°Ÿå°¿å˜§å•¶/è‘‰é…¸éˆ‰ (5-FU/LVï¼›Mayo Clinic æ–¹æ¡ˆï¼›n=604) æ²»ç™‚ã€‚</li><li>çµæœé¡¯ç¤ºï¼ŒCapecitabine çš„ â†’ åæ‡‰ç‡å„ªæ–¼ 5-FU/LV (26% vs. 17%ï¼›P&lt;0.0002)</li><li>äºçµ„åˆ†æè¡¨æ˜ï¼Œå³ä½¿åœ¨å…·æœ‰ âœ– ä¸è‰¯é å¾ŒæŒ‡æ¨™çš„ â†’ æ‚£è€…äºçµ„ä¸­ï¼ŒCapecitabine ä¹Ÿèƒ½å¤ ä¸€è‡´åœ°ç”¢ç”Ÿ â†ª æ›´å„ªç•°çš„ â†’ åæ‡‰ç‡ (P&lt;0.05) ã€‚</li><li>å„˜ç®¡å…©çµ„çš„ â†’ ä¸­ä½åæ‡‰æ™‚é–“å’ŒæŒçºŒæ™‚é–“ç›¸ä¼¼ï¼Œä½†ç–¾ç—…é€²å±•æ™‚é–“ (TTP) åœ¨å…©çµ„ä¸­ç›¸ç•¶ (é¢¨éšªæ¯” (HR) 0.997ï¼Œ95%ä¿¡å¿ƒå€é–“ (CI) 0.885-1.123ï¼ŒP=0.95ï¼›Capecitabine å’Œ 5-FU/LV çš„ â†’ ä¸­ä½ TTP åˆ†åˆ¥ç‚º 4.6 å’Œ 4.7 å€‹æœˆ) ã€‚</li><li>å¤šè®Šé‡ Cox å›æ­¸åˆ†æç¢ºå®šå¹´é½¡è¼ƒå°ã€è‚è½‰ç§»ã€å¤šè™•è½‰ç§»å’Œè¼ƒå·®çš„ Karnofsky è¡¨ç¾ç‹€æ…‹æ˜¯ TTP ä¸è‰¯é å¾ŒæŒ‡æ¨™çš„ â†’ ç¨ç«‹å› ç´ ã€‚</li><li>å…©çµ„çš„ â†’ æ•´é«”ç”Ÿå­˜ç‡ç›¸åŒ (HR 0.95ï¼Œ95% CI 0.84-1.06ï¼ŒP=0.48ï¼›Capecitabine å’Œ 5-FU/LV çš„ â†’ ä¸­ä½ç”Ÿå­˜æœŸåˆ†åˆ¥ç‚º 12.9 å’Œ 12.8 å€‹æœˆ) ã€‚</li><li>Capecitabine èˆ‡ i.v. 5-FU/LV ç›¸æ¯”ï¼Œåœ¨ä½œç‚º mCRC çš„ â†’ ä¸€ç·šæ²»ç™‚æ™‚ï¼Œç”¢ç”Ÿ â†ª äº†æ›´å„ªç•°çš„ â†’ åæ‡‰ç‡ã€ç›¸ç•¶çš„ TTP å’Œæ•´é«”ç”Ÿå­˜ç‡ï¼Œä¸¦å…·æœ‰æ›´å¥½çš„ â†’ å®‰å…¨æ€§å’Œä¾¿åˆ©æ€§</li><li>å°æ–¼éœ€è¦æ°Ÿå˜§å•¶å–®ç¨æ²»ç™‚çš„ â†’ æ‚£è€…ï¼Œæ‡‰å¼·çƒˆè€ƒæ…®ä½¿ç”¨ Capecitabine</li><li>åœ¨ I æœŸå’Œ II æœŸè©¦é©—å–å¾—é¼“èˆäººå¿ƒçš„ â†’ çµæœå¾Œï¼Œæ­£åœ¨é€²è¡Œ Capecitabine è¯åˆä¼Šç«‹æ›¿åº·ã€å¥§æ²™åˆ©éŠ¨å’Œæ”¾ç™‚çš„ â†’ éš¨æ©Ÿè©¦é©—</li><li>Capecitabine æ˜¯å–ä»£ i.v. 5-FU ä½œç‚ºçµç›´è…¸ç™Œæ²»ç™‚åŸºç¤çš„ â†’ åˆé©è—¥ç‰©ã€‚</li></ul></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>â†©ï¸ åå‘é€£çµ</h3><ul class=backlinks><li>ğŸ¤­æ²’æœ‰æ‰¾åˆ°åå‘é€£çµ</li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>ğŸ¤¯äº’å‹•åœ–</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>æœ¬ç¶²ç«™æ˜¯ç”± Hsieh-Ting Lin ä»¥â¤ï¸ ç”¨ <a href=https://github.com/jackyzha0/quartz>Quartz</a>é€™å€‹é…·æ±è¥¿ç¨®å‡ºä¾†ğŸª´ , Â© 2023</p><p><a href=https://www.buymeacoffee.com/htl.lizard><img src=https://cdn.buymeacoffee.com/buttons/v2/default-yellow.png width=200></a></p><ul><li><a href=https://www.physician.tw/>ğŸ é¦–é </a></li><li><a href=https://www.facebook.com/htlin.lizard>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://htlin222.medium.com>Medium</a></li></ul></footer></div></div></body></html>